Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Town Health International Medical Group Limited (3886.HK)
Sha Tin, HK
Town Health International Medical Group Limited is an investment holding company primarily engaged in the investment, operation, and provision of diverse healthcare and related services across mainland China and Hong Kong. Its operations are segmented into Hong Kong Medical Services, Hong Kong Managed Medical Network Business, Mainland Hospital Management and Medical Services, and other business activities. The group delivers a wide array of healthcare offerings, including cross-border healthcare, managed care programs, medical diagnostics, comprehensive health screenings, and specialized ophthalmology services. It also functions as a third-party administrator for medical networks. Complementary services encompass general medical and dental consultations, medical tourism, and property investment. Furthermore, Town Health expands its scope to beauty and cosmetic medicine, laboratory testing, hospital management, vision care, and business and corporate advisory. Non-core operations include trading listed securities, property leasing, and the distribution of medical equipment and pharmaceuticals. By the end of 2021, the company commanded a substantial network of 454 healthcare service points. This extensive infrastructure featured 259 general practice clinics, 75 specialist centers, 23 dental clinics, and 97 auxiliary service facilities. Founded in 1989, the company initially operated as Town Health International Investments Limited before rebranding to Town Health International Medical Group Limited in March 2014. Its corporate headquarters are situated in Shatin, Hong Kong.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.09% | -1.86% | -10.97% | -20.38% | -17.25% | -15.60% | -9.83% | -27.24% | -38.84% | -85.35% | -43.48% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%-2.6% Q4'25: -3.4% (vs Q4'23)
-
EPS growth Medical - Care Facilities: +19.2%+107.0% ★ Q4'25: +100.6% (vs Q4'23)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+6.2% Q4'25: +10.3% (vs Q4'23)
-
EBIT margin Medical - Care Facilities: +11.3%+4.4% Q4'25: +4.6% (vs Q4'23)
-
ROIC Medical - Care Facilities: +6.8%+2.2% Q4'25: +4.4% (vs Q4'23)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q4'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×0.70× ★ Q4'25: 0.26× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-11 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-05 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-04 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 5/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ka Tsan Choi | Chief Executive Officer & Chairman | 6M | male |
| Siu Wing Fok | Executive Director | 2M | — |
| Xiaoxue Zhang | Executive Director | 2M | female |
| Yu Huang | Executive Director | 2M | male |
| Wai Keung Lo | Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 3886.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
